Charles River Laboratories CRL Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$182.84M— | -$142.16M— | —— | —— | —— | ||
| $350.1M-11.8% | $403.31M+11.5% | $427.14M+25.6% | $430.17M+30.0% | $396.75M+23.1% | ||
| $80.33M+21.2% | $71.08M+1.7% | $70.69M-2.1% | $66.75M-11.8% | $66.29M-12.0% | ||
| $607.03M-21.8% | $737.65M+0.4% | $749.49M-5.9% | $787.45M+5.0% | $776.39M+10.2% | ||
| $215.74M+1.2% | $219.15M-5.9% | $205.82M-12.7% | $208.96M-20.5% | $213.15M-26.7% | ||
| $405.01M— | $0— | —— | —— | —— | ||
| -$571.69M-179% | -$209.32M+14.6% | -$192.62M+52.7% | -$180.25M+61.3% | -$204.77M+57.4% | ||
| $215.83M-53.4% | $360.67M+203% | $360.7M+203% | $461.39M+2,402% | $462.96M+3,094% | ||
| $1.72B+44.0% | $1.23B+13.5% | $1.18B-17.2% | $1.3B+5.5% | $1.2B+35.3% | ||
| $1.56B+15.2% | $1.35B-9.7% | $1.32B-19.5% | $1.39B-8.4% | $1.35B+36.9% | ||
| -$83.68M+87.6% | -$536.73M+2.6% | -$560.74M— | -$615.66M— | -$674.6M— | ||
| -$33.53M— | $10.43M— | -$2.42M— | —— | —— | ||
| $391.29M-30.5% | $518.49M+3.4% | $543.67M-3.0% | $578.5M+18.8% | $563.24M+36.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Charles River Laboratories generate?
- Charles River Laboratories (CRL) generated $607.0M in operating cash flow over the trailing twelve months.
- What is Charles River Laboratories's free cash flow?
- After $215.7M of capital expenditures, Charles River Laboratories's free cash flow was $391.3M over the trailing twelve months, down 30.5% year over year.
- Where does Charles River Laboratories's cash flow data come from?
- Every line is extracted from Charles River Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
